Phase I Trial of Lithium and Tretinoin for Treatment of Relapsed and Refractory Non-promyelocytic Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

Phase I Trial of Lithium and Tretinoin for Treatment of Relapsed and Refractory Non-promyelocytic Acute Myeloid Leukemia

Published:2020-03-10 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Ueda Masumi,Stefan Tammy,Stetson Lindsay,Ignatz-Hoover James J.,Tomlinson Benjamin,Creger Richard J.,Cooper Brenda,Lazarus Hillard M.,de Lima Marcos,Wald David N.,Caimi Paolo F.

Funder

Leukemia and Lymphoma Society

American Cancer Society

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference34 articles.

1. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia;Lo-Coco;N Engl J Med,2013

2. GSK3 is a regulator of RAR-mediated differentiation;Gupta;Leukemia,2012

3. The intersection of genetic and chemical genomic screens identifies GSK-3alpha as a target in human acute myeloid leukemia;Banerji;J Clin Investig,2012

4. GSK3 inhibitors enhance retinoic acid receptor activity and induce the differentiation of retinoic acid-sensitive myeloid leukemia cells;Si;Leukemia,2011

5. Glycogen synthase kinase−3beta inhibitors suppress leukemia cell growth;Song;Exp Hematol,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systems Biology for Drug Target Discovery in Acute Myeloid Leukemia;International Journal of Molecular Sciences;2024-04-23

2. Valproate and lithium: Old drugs for new pharmacological approaches in brain tumors?;Cancer Letters;2023-04

3. Lithium: A Promising Anticancer Agent;Life;2023-02-15

4. Lithium in Cancer Therapy: Friend or Foe?;Cancers;2023-02-08

5. Novel Insights into the Role of Kras in Myeloid Differentiation: Engaging with Wnt/β-Catenin Signaling;Cells;2023-01-14